Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure 
Visa to Move European Headquarters to London’s Canary Wharf 
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp 
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data 
Gold Prices Steady as Markets Await Key U.S. Data and Expected Fed Rate Cut 
BOJ Faces Pressure for Clarity, but Neutral Rate Estimates Likely to Stay Vague 
Dollar Weakens Ahead of Expected Federal Reserve Rate Cut 
ExxonMobil to Shut Older Singapore Steam Cracker Amid Global Petrochemical Downturn 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 
Barry Callebaut has halted manufacturing operations at its Weize chocolate plant in Belgium as a precautionary measure while conducting its root cause analysis and risk assessment after detecting salmonella in a production lot.
The company identified lecithin as the source of the contamination.
All chocolate products manufactured at the facility since June 25 have been placed on hold.
After the analysis, the lines will be cleaned and sanitized before production can resume.
Barry Callebaut, which informed the Belgian food authorities (FAVV) about the incident, said that their robust food safety programs allowed them to identify lecithin as the source of the contamination quickly.
The company added that they are reaching out to all customers who may have received impacted products.
The news comes after Ferrero temporarily suspended production at its Arlon facility in Belgium after the site was linked to a salmonella outbreak.
